Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial

Hong, Sung‐Jin; Lee, Seung‐Jun; Suh, Yongsung; Ho Yun, Kyeong; Soo Kang, Tae; Shin, Sanghoon; Woo Kwon, Sung; Lee, Jun‐Won; Cho, Deok‐Kyu; Park, Jong‐Kwan; Bae, Jang‐Whan; Cheol Kang, Woong; Kim, Seunghwan; Lee, Yong‐Joon; Ahn, Chul‐Min; Kim, Jung‐Sun; Kim, Byeong‐Keuk; Ko, Young‐Guk; Choi, Donghoon; Jang, Yangsoo; Hong, Myeong‐Ki; behalf of the T-PASS (Ticagrelor Monotherapy in Patients Treated With New-Generation Drug-Eluting Stents for Acute Coronary Syndrome) Investigators, on

doi:10.1161/circulationaha.123.066943

Public

Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial

Published in Circulation • Oct 25, 2023

Authors:

Sung‐Jin Hong

Seung‐Jun Lee

Yongsung Suh

Abstract

BACKGROUND: Stopping aspirin within 1 month after implantation of a drug-eluting stent for ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary syndrome. The aim of this study was to investigate whether ticagrelor monotherapy after <1 month of dual antiplatelet ...

Subject

Medicine

Ticagrelor

Aspirin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!